These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 2374280

  • 1. Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine.
    JAMA; 1990 Aug 08; 264(6):752-4. PubMed ID: 2374280
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intracavernous injections for impotence.
    Med Lett Drugs Ther; 1987 Oct 23; 29(751):95-6. PubMed ID: 3670212
    [No Abstract] [Full Text] [Related]

  • 5. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
    Wyndaele JJ, de Meyer JM, de Sy WA, Claessens H.
    Paraplegia; 1986 Oct 23; 24(5):271-5. PubMed ID: 3774363
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic roles of intracavernosal papaverine.
    Goldstein I, Payton T, Padma-Nathan H.
    Cardiovasc Intervent Radiol; 1988 Aug 23; 11(4):237-9. PubMed ID: 3147138
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S.
    Arch Esp Urol; 2002 Jun 23; 55(5):475-82. PubMed ID: 12174413
    [No Abstract] [Full Text] [Related]

  • 10. The use of vasoactive agents in the treatment of erectile impotence.
    Fried FA.
    N C Med J; 1990 Jun 23; 51(6):295-6. PubMed ID: 2366889
    [No Abstract] [Full Text] [Related]

  • 11. Vasoactive intracavernous pharmacotherapy.
    Sidi AA.
    Urol Clin North Am; 1988 Feb 23; 15(1):95-101. PubMed ID: 2449756
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intracavernous drug delivery system: an alternative to intracavernous injection in the treatment of impotence?
    Stief CG, Wetterauer U, Kulvelis F, Popken G, Staubesand J, Sommerkamp H.
    Urol Int; 1990 Feb 23; 45(6):321-5. PubMed ID: 2288047
    [Abstract] [Full Text] [Related]

  • 14. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
    von Heyden B, Donatucci CF, Kaula N, Lue TF.
    J Urol; 1993 May 23; 149(5 Pt 2):1288-90. PubMed ID: 8479018
    [Abstract] [Full Text] [Related]

  • 15. How safe is the treatment of impotence with intracavernous autoinjection?
    Zentgraf M, Ludwig G, Ziegler M.
    Eur Urol; 1989 May 23; 16(3):165-71. PubMed ID: 2663519
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impotence: treatment by autoinjection of vasoactive drugs.
    Williams G, Mulcahy MJ, Kiely EA.
    Br Med J (Clin Res Ed); 1987 Sep 05; 295(6598):595-6. PubMed ID: 3117249
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Intracavernous pharmacotherapy for management of erectile dysfunction in spinal cord injury.
    Lloyd LK, Richards JS.
    Paraplegia; 1989 Dec 05; 27(6):457-64. PubMed ID: 2608299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.